Boehringer and University of Dundee Highlight Successful PROTAC Drug Discovery Program and Extend Their Ongoing Anti-Cancer Alliance Read more
Deciphera and Zai Lab Limited Announce an Exclusive License Agreement for Ripretinib in Greater China Read more
FDA Grants Genentech’s Polivy Accelerated Approval for People with Previously Treated Aggressive Lymphoma Read more
Hoth Therapeutics to Begin Production of BioLexa Therapeutic for Upcoming Toxicology and Clinical Trials Read more
Rick Thompson CEO at Findacure invitation to SMI’s Orphan Drugs & Rare Diseases Conference 2019 Read more
CStone and Bayer announce global collaboration to evaluate PD-L1 monoclonal antibody CS1001 in combination with regorafenib Read more